Including pre-existing genomic data, we exhaustively compared CHEK2 primary BC (pBC) genomes to pBC genomes from BRCA1/2 mutation carriers, pBCs that displayed HRD and ER− and ER+ pBCs, totaling to 574 pBC genomes. The gene discussed is ESR1; the disease is breast cancer.